These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Oroxyloside prevents dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB pathway through PPARγ activation. Wang X; Sun Y; Zhao Y; Ding Y; Zhang X; Kong L; Li Z; Guo Q; Zhao L Biochem Pharmacol; 2016 Apr; 106():70-81. PubMed ID: 26947454 [TBL] [Abstract][Full Text] [Related]
7. Effect of Rosiglitazone, the Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, on Apoptosis, Inflammatory Cytokines and Oxidative Stress in pentylenetetrazole-Induced Seizures in Kindled Mice. Li J; Chen S; Wang F; Zhang J; Zeyghami MA; Koohsar F; Ayatollahi AA; Amini A Neurochem Res; 2023 Sep; 48(9):2870-2880. PubMed ID: 37204549 [TBL] [Abstract][Full Text] [Related]
8. A selective peroxisome proliferator-activated receptor-γ agonist benefited propionic acid induced autism-like behavioral phenotypes in rats by attenuation of neuroinflammation and oxidative stress. Mirza R; Sharma B Chem Biol Interact; 2019 Sep; 311():108758. PubMed ID: 31348919 [TBL] [Abstract][Full Text] [Related]
9. Chronological in vivo imaging reveals endothelial inflammation prior to neutrophils accumulation and lipid deposition in HCD-fed zebrafish. Luo H; Li QQ; Wu N; Shen YG; Liao WT; Yang Y; Dong E; Zhang GM; Liu BR; Yue XZ; Tang XQ; Yang HS Atherosclerosis; 2019 Nov; 290():125-135. PubMed ID: 31614249 [TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor-gamma activation suppresses HIV-1 replication in an animal model of encephalitis. Potula R; Ramirez SH; Knipe B; Leibhart J; Schall K; Heilman D; Morsey B; Mercer A; Papugani A; Dou H; Persidsky Y AIDS; 2008 Aug; 22(13):1539-49. PubMed ID: 18670212 [TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor-gamma targeting nanomedicine promotes cardiac healing after acute myocardial infarction by skewing monocyte/macrophage polarization in preclinical animal models. Tokutome M; Matoba T; Nakano Y; Okahara A; Fujiwara M; Koga JI; Nakano K; Tsutsui H; Egashira K Cardiovasc Res; 2019 Feb; 115(2):419-431. PubMed ID: 30084995 [TBL] [Abstract][Full Text] [Related]
12. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism. Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073 [TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents. Tureyen K; Kapadia R; Bowen KK; Satriotomo I; Liang J; Feinstein DL; Vemuganti R J Neurochem; 2007 Apr; 101(1):41-56. PubMed ID: 17394460 [TBL] [Abstract][Full Text] [Related]
14. Luteoloside attenuates neuroinflammation in focal cerebral ischemia in rats via regulation of the PPARγ/Nrf2/NF-κB signaling pathway. Li Q; Tian Z; Wang M; Kou J; Wang C; Rong X; Li J; Xie X; Pang X Int Immunopharmacol; 2019 Jan; 66():309-316. PubMed ID: 30502652 [TBL] [Abstract][Full Text] [Related]
15. The antidepressant-like effects of pioglitazone in a chronic mild stress mouse model are associated with PPARγ-mediated alteration of microglial activation phenotypes. Zhao Q; Wu X; Yan S; Xie X; Fan Y; Zhang J; Peng C; You Z J Neuroinflammation; 2016 Oct; 13(1):259. PubMed ID: 27716270 [TBL] [Abstract][Full Text] [Related]
16. Peroxisome Proliferator-Activated Receptor γ Agonist Rosiglitazone Protects Blood-Brain Barrier Integrity Following Diffuse Axonal Injury by Decreasing the Levels of Inflammatory Mediators Through a Caveolin-1-Dependent Pathway. Zhao Y; Wei X; Song J; Zhang M; Huang T; Qin J Inflammation; 2019 Jun; 42(3):841-856. PubMed ID: 30488141 [TBL] [Abstract][Full Text] [Related]
17. Fenretinide inhibits macrophage inflammatory mediators and controls hypertension in spontaneously hypertensive rats via the peroxisome proliferator-activated receptor gamma pathway. Lin CH; Lee SY; Zhang CC; Du YF; Hung HC; Wu HT; Ou HY Drug Des Devel Ther; 2016; 10():3591-3597. PubMed ID: 27843299 [TBL] [Abstract][Full Text] [Related]
18. The role of GLS1-mediated glutaminolysis/2-HG/H3K4me3 and GSH/ROS signals in Th17 responses counteracted by PPARγ agonists. Miao Y; Zheng Y; Geng Y; Yang L; Cao N; Dai Y; Wei Z Theranostics; 2021; 11(9):4531-4548. PubMed ID: 33754076 [No Abstract] [Full Text] [Related]
19. Peroxisome proliferation-activated receptor (PPAR)gamma is not necessary for synthetic PPARgamma agonist inhibition of inducible nitric-oxide synthase and nitric oxide. Crosby MB; Svenson JL; Zhang J; Nicol CJ; Gonzalez FJ; Gilkeson GS J Pharmacol Exp Ther; 2005 Jan; 312(1):69-76. PubMed ID: 15356214 [TBL] [Abstract][Full Text] [Related]
20. Pro-inflammatory cytokines negatively regulate PPARγ mediated gene expression in both human and murine macrophages via multiple mechanisms. Nagy ZS; Czimmerer Z; Szanto A; Nagy L Immunobiology; 2013 Nov; 218(11):1336-44. PubMed ID: 23870825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]